CFN Media

January 17, 2017 09:15 ET

Exclusive Interview with Tetra Bio-Pharma CSO Discussing Task Force Recommendations, DEA -- CFN Media

SEATTLE, WA--(Marketwired - Jan 17, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an exclusive interview and story covering the effect recent Canadian Cannabis Task Force recommendations and DEA actions could have on Tetra Bio-Pharma Inc. (OTC PINK: GRPOF) (CSE: TBP) as the company continues development of smokable marijuana as treatment for a variety of conditions.

The United States government has permitted individual states to legalize the drug, but the Drug Enforcement Administration recently cracked down on cannabidiol (CBD) makers and President Trump's cabinet picks are opponents of legalization. In Canada, voters approved the nationwide legalization of cannabis with the election of Prime Minister Trudeau, but the framework governing the program is only now starting to become clear.

Tetra Bio-Pharma has already started down the pharmaceutical path by undergoing clinical trials for medical cannabis in its natural form. The company believes that smokable marijuana may provide patients with a better natural alternative to synthetic cannabinoids and extracts. With the large number of existing users, the company also has access to a lot of data to support its clinical studies.

In the interview, Tetra's Chief Science Officer, Dr. Guy Chamberland, points out that medical cannabis patients are keen on receiving reimbursements since they cannot afford regular access without it. At the same time, physicians have been hesitant to prescribe medical cannabis without robust clinical trials demonstrating both safety and efficacy. These demands could lead to a much more 'pharmaceutical' approach than existing medical cannabis programs.

Please follow the link to read the full article and see the video interview:

Learn how to become a CFN Media client company, brand or entrepreneur:

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand:

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:

About CFN Media
CFN Media (CannabisFN), the leading creative agency and media network dedicated to legal cannabis, helps marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit:

Contact Information